Study to Evaluate the Immunogenicity, Safety, and Tolerability of a Tick-Borne Encephalitis (TBE) Vaccine in Healthy Japanese Participants 1 Year of Age and Older
Clinical trial NCT04648241 · COMPLETED
Trial details
- NCT number
- NCT04648241
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-18
- Primary completion
- 2022-02-21
- Enrollment
- 165
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.